Central Sensitization in Migraine: A Narrative ReviewKeisuke Suzuki, Koichi Hirata, Shiho Suzuki et al.|Journal of Pain Research|2022Cited by 108
Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in JapanKeisuke Suzuki, Koichi Hirata, Yasuo Haruyama et al.|Cephalalgia|2023Cited by 53
Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson’s Disease and Their Caregivers: A Single-Center Survey in Tochigi PrefectureKeisuke Suzuki, Koichi Hirata, Kei Funakoshi et al.|Journal of Parkinson s Disease|2021Cited by 52
Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in JapanShiho Suzuki, Koichi Hirata, Keisuke Suzuki et al.|Frontiers in Neurology|2023Cited by 48
Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patents with migraineKeisuke Suzuki, Koichi Hirata, Shiho Suzuki et al.|The Journal of Headache and Pain|2021Cited by 37